Ziprasidone
Brand names: Geodon
Atypical Antipsychotics (Second-Generation)Key Takeaway
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
⚠ FDA Black Box Warning
Increased Mortality in Elderly Patients with Dementia-Related Psychosis: Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of 17 placebo-controlled trials (modal duration 10 weeks) in these patients showed a 1.6- to 1.7-fold increase in death compared to placebo. Ziprasidone is not approved for the treatment of patients with dementia-related psychosis [1].
Emergency Information
Poison Control: 1-800-222-1222
How does Ziprasidone work?
Ziprasidone works by modulating multiple neurotransmitter systems in the brain [1, 2]. In schizophrenia and bipolar disorder, certain brain chemicals — particularly dopamine and serotonin — are imbalanced.
Ziprasidone blocks dopamine D2 receptors, which helps reduce psychotic symptoms such as hallucinations, delusions, and disorganized thinking [1, 2]. It also blocks serotonin 5-HT2A receptors, which is thought to contribute to its efficacy against negative symptoms (social withdrawal, lack of motivation) and its lower risk of movement-related side effects compared to older antipsychotics [2].
Additionally, ziprasidone inhibits the reuptake of both serotonin and norepinephrine, which may provide modest mood-stabilizing and antidepressant effects [2]. This combination of receptor-blocking and reuptake-inhibiting activity gives ziprasidone a unique pharmacological profile among atypical antipsychotics.
The result of these actions is improved thought organization, reduced hallucinations and delusions, stabilized mood, and less agitation.
What to expect when starting Ziprasidone
Days 1-3: Ziprasidone typically takes several days to begin producing noticeable effects on psychotic symptoms [1]. During the initial period, you may experience drowsiness, dizziness, or mild nausea as your body adjusts. These side effects usually improve with time.
Weeks 1-2: Symptoms of agitation and insomnia often improve within the first week [1]. Some improvement in psychotic symptoms (hallucinations, delusions) may begin during this period, though full antipsychotic effects take longer to develop.
Weeks 4-6: Significant improvement in schizophrenia symptoms typically occurs within 4-6 weeks of treatment at an adequate dose [1, 2]. For bipolar mania, response is often faster, within 1-3 weeks.
Important — take with food: Ziprasidone must be taken with a meal of at least 500 calories to ensure adequate absorption [1]. Without food, absorption drops by approximately 50%, significantly reducing the medication's effectiveness.
What are the common side effects of Ziprasidone?
Common
- Somnolence (drowsiness)8-14%
- Nausea6-10%
- Constipation5-9%
- Dizziness5-8%
- Restlessness (akathisia)5-8%
- Headache4-8%
- Extrapyramidal symptoms (muscle stiffness, tremor)4-6%
- Weight gain2-3%
What are the serious side effects of Ziprasidone?
Serious
- Tardive dyskinesiaUncommon with atypical antipsychotics
- Metabolic changes (hyperglycemia, dyslipidemia)Less common than with other atypical antipsychotics
- Orthostatic hypotension5%
- QT prolongation and risk of torsades de pointesDose-related; clinically significant arrhythmia is rare
- Neuroleptic malignant syndrome (NMS)Rare
What drugs interact with Ziprasidone?
- ContraindicatedQT-prolonging drugs (sotalol, amiodarone, thioridazine, quinidine, dofetilide, pimozide) — Ziprasidone itself prolongs the QT interval. Concomitant use with other QT-prolonging drugs is contraindicated due to risk of life-threatening cardiac arrhythmias (torsades de pointes) [1].
- MajorCarbamazepine and other CYP3A4 inducers — Carbamazepine reduces ziprasidone levels by approximately 35%. Higher doses of ziprasidone may be needed [1].
- ModerateKetoconazole and other strong CYP3A4 inhibitors — Ketoconazole increases ziprasidone AUC by approximately 35%. Caution is advised, particularly regarding QT prolongation risk [1].
- ModerateAntihypertensive medications — Ziprasidone can cause orthostatic hypotension. Additive blood pressure lowering may occur with antihypertensive agents [1].
- MajorLevodopa and dopamine agonists — Ziprasidone blocks dopamine receptors and may antagonize the effects of levodopa and other dopamine agonists used for Parkinson disease [1].
Can I eat certain foods or drink alcohol with Ziprasidone?
Food (CRITICAL): Ziprasidone MUST be taken with food — specifically a meal of at least 500 calories [1]. Without food, absorption is reduced by approximately 50%, which can make the medication significantly less effective. This is one of the most important instructions for patients taking ziprasidone.
Alcohol: Alcohol should be avoided while taking ziprasidone. Both substances depress the central nervous system, and combining them can worsen drowsiness, dizziness, and impaired coordination. Alcohol may also worsen orthostatic hypotension and potentially affect the QT interval.
Grapefruit: Use caution with grapefruit juice, as it inhibits CYP3A4 and may modestly increase ziprasidone levels [1].
What is the typical dosage for Ziprasidone?
Ziprasidone dosing varies by indication and formulation [1].
Schizophrenia (oral capsules): - Starting dose: 20 mg twice daily with food [1] - Titration: Adjust at intervals of at least 2 days, in increments of up to 20 mg twice daily - Usual maintenance dose: 20-80 mg twice daily [1] - Maximum dose: 80 mg twice daily (160 mg/day)
Bipolar I disorder, acute manic/mixed episodes (oral): - Day 1: 40 mg twice daily with food [1] - Day 2: 60-80 mg twice daily with food - Maintenance: 40-80 mg twice daily [1]
Acute agitation in schizophrenia (intramuscular): - 10-20 mg IM as needed [1] - 10 mg dose may be given every 2 hours; 20 mg dose may be given every 4 hours - Maximum: 40 mg/day IM - Switch to oral as soon as possible
All oral doses must be taken with food (at least 500 calories per meal) [1].
No specific dose adjustment required for renal or hepatic impairment, though the IM formulation contains cyclodextrin which is renally cleared — use oral form in severe renal impairment [1].
How much does Ziprasidone cost?
Ziprasidone is available as a generic medication [1, 3].
Typical pricing (approximate 2025 prices): - Brand-name Geodon capsules: $15-25 per capsule ($900-1,500/month) - Generic ziprasidone capsules: $0.50-2 per capsule ($30-120/month)
Savings strategies: - Generic substitution: Generic ziprasidone has been available since 2012 [3]. Most prescriptions are now filled generically. - Pharmacy discount programs: GoodRx and similar tools can reduce generic prices to as low as $20-40/month. - Patient assistance programs: Pfizer (original manufacturer) and generic manufacturers offer assistance for qualifying patients. - Insurance: Most insurance plans cover generic ziprasidone. Prior authorization may be required.
Is Ziprasidone safe during pregnancy or breastfeeding?
Pregnancy: Ziprasidone should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus [1]. Neonates exposed to antipsychotics during the third trimester are at risk for extrapyramidal and/or withdrawal symptoms (agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress, feeding disorder) after delivery. These symptoms may be self-limiting or require hospitalization.
Breastfeeding: It is not known whether ziprasidone is excreted in human breast milk [1]. Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug.
Is there a generic version of Ziprasidone?
Generic ziprasidone has been available since 2012 [3].
Brand name (Geodon): - Manufactured by Pfizer - Capsules: 20 mg, 40 mg, 60 mg, 80 mg - Intramuscular injection: 20 mg/mL
Generic ziprasidone: - Multiple manufacturers produce FDA-approved generics (oral capsules) - Rated therapeutically equivalent (AB-rated) by the FDA - Available in all capsule strengths - Generic IM formulation may have limited availability
Among atypical antipsychotics, ziprasidone is notable for its relatively favorable metabolic profile — patients tend to gain less weight and experience fewer cholesterol/blood sugar changes compared to olanzapine, quetiapine, or clozapine [2]. This makes it an important option for patients concerned about metabolic side effects.
For Caregivers
If you are caring for someone who takes ziprasidone:
Food requirement: This is the most critical practical consideration. Ziprasidone must be taken with a substantial meal (at least 500 calories) each time [1]. Without food, the medication is only half as effective. Help ensure meals are available at dosing times.
Heart monitoring: Ziprasidone can prolong the QT interval, which affects heart rhythm [1]. Ensure your loved one attends all scheduled ECG appointments and blood tests. Report any palpitations, fainting, or dizziness immediately.
Watch for side effects: Monitor for excessive drowsiness (especially when starting), movement abnormalities (muscle stiffness, tremor, involuntary movements), and signs of metabolic changes. Any high fever with severe muscle rigidity could indicate neuroleptic malignant syndrome — seek emergency care immediately [1].
Medication adherence: Do not stop ziprasidone suddenly without medical guidance, as this can cause symptom recurrence [1].
Frequently asked questions about Ziprasidone
References
- [Regulatory] Geodon (ziprasidone) prescribing information. Pfizer Inc. Revised 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020825s059lbl.pdf Accessed 2026-03-01.
- [Clinical] Leucht S, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382(9896):951-962. https://pubmed.ncbi.nlm.nih.gov/23810019/ Accessed 2026-03-01.
- [Observational] Ziprasidone. In: IBM Micromedex DRUGDEX (electronic version). Merative. https://www.micromedexsolutions.com/ Accessed 2026-03-01.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: